Assistant Professor of Clinical Pharmacy
University of California, San Diego
San Diego, California
Dr. Jacinda Abdul-Mutakabbir is an Assistant Professor of Clinical Pharmacy at the University of California San Diego in the Skaggs School of Pharmacy and the Division of the Black Diaspora and African American Studies. She completed her Doctorate in Pharmacy at the University of Saint Joseph School of Pharmacy, in Hartford, CT. Following pharmacy school, she completed her pharmacy residency at the Howard University Hospital in Washington, DC. She also completed an Infectious Disease Pharmacokinetics/ Pharmacodynamics (PK/PD) Research Fellowship under the tutelage of Dr. Michael J. Rybak PharmD, MPH, PhD. She went on to earn a Masters of Public Health at Wayne State University in Detroit, MI. Her research in mitigating antimicrobial resistance has led her to be recognized by the European Congress of Clinical Microbiology and Infectious Diseases as one of their 30 under 30 outstanding young scientists for their ECCMID 2021 31st annual meeting. Dr. Abdul-Mutakabbir is also dedicated to magnifying and rectifying health inequities in minoritized communities. To that point, she currently serves as the Lead Pharmacist and Educator for Congregations Organized for Prophetic Engagement-Health Equity Collaborative. Her dedication to improving public health has been recognized by the United States Public Health Services, as she was the 2017 recipient of the USPHS Outstanding Service Award and named the awardee of the 2022 American Pharmacists Association-Immunization Champion (Honorable Mention) award. She was also the 2021 recipient of the Society of Infectious Disease Gita Patel Best Practice Award, the 2021 recipient of the Wayne State University Warrior of Distinction of Alumni Award. Dr. Abdul-Mutakabbir continues to be an active member of several professional organizations, including the American Society of Microbiology (ASM), the Infectious Diseases Society of America (IDSA), and the Society of Infectious Disease Pharmacists (SIDP).
Sunday, March 26, 2023
10:00 AM – 11:00 AM
Disclosure(s): Entasis Therapeutics: Advisory Committee/Board Member (Ongoing); Shionogi: Advisory Committee/Board Member (Ongoing), Consultant (Ongoing)
Sunday, March 26, 2023
3:30 PM – 4:30 PM
Disclosure(s): Entasis Therapeutics: Advisory Committee/Board Member (Ongoing); Shionogi: Advisory Committee/Board Member (Ongoing), Consultant (Ongoing)